During T cell development, cells that fail to meet stringent selection criteria undergo programmed cell death. Thymocyte and peripheral T cell susceptibility to apoptosis is influenced by expression of Bcl-2 family members, some of which are expressed in a developmentally patterned manner. We previously showed developmentally regulated expression of A1, an anti-apoptotic Bcl-2 family member, among B cell developmental subsets. Here we show that cells of the T lineage also express A1 in a developmentally regulated manner. Both A1 mRNA and A1 protein are readily detectable in the thymus, and while present among DN cells, A1 mRNA is up-regulated to very high levels among double-positive (DP) thymocytes. It is then down-regulated to moderate levels among single-positive (SP) thymocytes, and finally expressed at~25-fold lower levels among mature SP CD4 ⍣ and CD8 ⍣ lymph node T cells than among DP thymocytes. Furthermore, we find that in vitro TCR ligation up-regulates A1 expression among both DP and SP thymocytes. Together, these data show that A1 expression is developmentally regulated in T lymphocytes and is responsive to TCR signaling, suggesting that A1 may play a role in maintaining the viability of DP thymocytes.
Introduction
During T cell differentiation, up to 97% of developing thymoanti-apoptotic members Bcl-2 and Bcl-x L are developmentally regulated in T cells, and overexpression of either can yield cytes die by apoptosis (1) (2) (3) (4) . This death reflects both negative selection and the lack of positive selection (5-9). Early in increased numbers of particular thymocyte subpopulations and mature T cells (17) (18) (19) . Further, thymocytes that overthymic development, productive TCR β gene rearrangement (10) and pre-TCR formation (11) are required for CD4 -CD8 -express either Bcl-2 or Bcl-x L survive longer in vitro and better resist γ-irradiation-or corticosteroid-induced death (17-21). [double-negative (DN)] thymocytes to advance to the CD4 ϩ CD8 ϩ [double-positive (DP)] stage. Likewise, survival
The recently identified Bcl-2 family member, A1, shares many properties with Bcl-2 and Bcl-x L . Like these proteins, of DP thymocytes requires TCR-MHC interactions that are sufficiently avid to afford positive selection, yet not strong A1 contains all major homology domains of the Bcl-2 family (22, 23). In addition, A1 slows cell death when transfected enough to induce negative selection. Only cells that meet these criteria mature into single-positive (SP) CD4 ϩ or CD8 ϩ into cell lines (24-26) and can heterodimerize with the proapoptotic Bax (27) . Unlike Bcl-2 and Bcl-x L , however, A1 T cells, exit the thymus and enter the long-lived recirculating T cell pool. The extensive losses during receptor-mediated activity is not modulated via dimerization with the pro-apoptotic family member, Bad (28) . In addition, A1 lacks an selection in situ, as well as their sensitivity to glucocorticoids (12,13), γ-irradiation (14) and TCR-CD3-mediated signals N-terminal loop of charged amino acids (29) shared by most other members. This region is protease sensitive (30) , and (15,16), suggest that thymocytes are exquisitely susceptible to induced apoptotic death.
its deletion enhances anti-apoptotic activity (31) and may lengthen biological half-life. These differences suggest that Gene products of the Bcl-2 family may be pivotal in establishing thresholds of susceptibility to programmed cell A1 may inhibit cell death more potently than Bcl-2 or Bcl-x L .
We recently showed that A1 mRNA is expressed at low death among developing T cell subsets. For example, the levels throughout B cell development in the bone marrow and actin was from Accurate Chemical and Scientific (Westbury, NY), and goat anti-mouse IgG1-HRP was from Southern periphery, but is up-regulated~10-fold as cells enter the long-lived mature B cell pool (32) . Because both T and B cell Biotechnology. differentiation involve discrete developmental stages that vary MACS in susceptibility to induced cell death, we reasoned that A1
To obtain enriched populations of DN and SP thymocytes, might also be regulated during thymocyte development. In thymi from young adult mice were depleted of either CD4 ϩ this study, we therefore compared the expression of A1 or CD8 ϩ cells by MACS. Thymocytes were resuspended at message and protein among thymic and lymph node (LN) 10 7 cells/90 µl MACS staining buffer (a degassed solution of T cell subpopulations.
PBS with 0.5% BSA and 2 mM EDTA) and incubated with The results indicate that A1 mRNA is expressed at high 10 µl anti-CD4 or anti-CD8α microbeads for 30 min on ice. levels in thymic T cells and is found at the highest levels
The thymocytes were then washed with Ͼ10 volumes buffer, among DP thymocytes. It is down-regulated in SP thymocytes pelleted at 300 g and resuspended in 500 µl buffer/10 8 cells. and expressed at~25-fold lower levels among SP peripheral CS-negative depletion columns (Miltenyi Biotech, Auburn, T cell populations. In addition, we investigate the respons-CA) were placed in the magnetic field of a MACS separator iveness of A1 to TCR signaling and show that although A1
(Miltenyi Biotech), filled with ice-cold staining buffer and expression is not dependent on TCR-MHC interactions, it can loaded with 2ϫ10 8 cells. The column was washed with 5 be up-regulated by TCR signaling. Finally, we verify that A1
volumes of ice-cold buffer and the negative fraction was encodes an~20 kDa protein, as predicted by its cDNA collected through a 21 gauge needle. sequence, and demonstrate that A1 protein expression paralTo obtain enriched LN T cells for Western blot analysis, lels mRNA expression during T cell differentiation. Together, LN preparations were depleted of sIgM ϩ cells in a similar these findings indicate that A1 is modulated at critical points procedure. LN cells were first resuspended at 2ϫ10 6 /ml in in T cell differentiation, likely via receptor-associated signaling MACS staining buffer and stained with anti-IgM-biotin for 30 pathways.
min on ice, then washed, pelleted, and resuspended at 10 7 cells/90 µl staining buffer. The cells were then stained with Methods 10 µl streptavidin-microbeads (Miltenyi Biotech) for 15 min on ice. The negative fraction was purified and collected as Mice detailed above.
BALB/cJ mice, 3-8 weeks old, were purchased from Jackson Flow cytometric analysis Laboratory (Bar Harbor, ME) and C57BL/6 mice, 3 weeks old, Cells were incubated at 2ϫ10 6 /ml in FACS staining buffer were purchased from Taconic Laboratories (Germantown, (PBS with 0.5% BSA) and pre-incubated for 10 min on ice NY). MHC-deficient mice, initially provided by Drs A. Singer with 5 mg/ml each of rat, hamster and mouse IgG. Cells and T. Guinter (National Cancer Institute, Bethesda, MD), were then stained with fluorochrome-or biotin-conjugated were maintained in the breeding colony of J. Punt. These antibodies (1-10 µg/ml cells) for 30 min on ice and washed mice had been generated according to Grusby et al. (33) , in ice-cold staining buffer. When biotinylated antibodies were by crossing the I-Aβ -/-line of MHC class II-deficient mice used, cells were then incubated with streptavidin-Red670 (34) with β 2 -microglobulin-deficient mice (35) .
(Gibco/BRL, Bethesda, MD) for 5 min and re-washed. For simple analysis, cells were fixed with 1% paraformaldehyde Cell preparations and refrigerated in the dark until analysis. For cell sorting, Lymphocytes were flushed from thymi and LN using ice-cold cells were filtered through a 35 µm strainer (Becton Dickinson, DMEM. Cells were then pelleted at 300 g and resuspended Franklin Lakes, NJ) and kept on ice in FACS staining buffer. in 37°C ammonium chloride-Tris for 5 min to lyse red blood Cells were analyzed on a Becton Dickinson FACScan for cells, then re-pelleted and resuspended in cold DMEM. Cells simple profile analysis and on a FACStar Plus or FACS Vantage from at least three mice were pooled for each experimental for cell sorting. For both instruments, an argon-ion laser preparation.
was tuned to a single-line emission at 488 nm. A 530DF30 bandpass filter was used in FL1 to capture FITC fluorescence, Antibodies a 575DF26 bandpass filter in FL2 to capture PE fluorescence The blocking antibodies, normal mouse, rat, hamster, donkey and a 660DF20 bandpass filter in FL3 to capture PE-Cy5 and goat IgG were purchased from Jackson ImmunoResearch tandem conjugate (Red670) fluorescence. Standard instru-(West Grove, PA). For flow cytometric analyses, anti-CD4-ment settings and standard target channels were established FITC (clone L3T4), anti-CD8α-phycoerythrin (PE) (clone 53-with filters in place using chick red blood cells for the FACS 6.7), anti-CD3ε-biotin (clone 145-2C11) and antiVantage and Rainbow particle calibration beads (Spherotech, CD45(B220)-allophycocyanin (clone RA3-6B2) were purLibertyville, IL) for the FACStar Plus. Instrument performance chased from PharMingen (San Diego, CA). For MACS, antiwas monitored on a daily basis. Data was acquired and IgM-biotin was purchased from Southern Biotechnology analyzed with Lysys II and CellQuest software. Viable lympho-(Birmingham, AL), and anti-CD4 and anti-CD8α microbeads cytes were identified by gating on forward and side scatter. were purchased from Miltenyi Biotech (Auburn, CA). For
Isolation of mRNA and preparation of cDNA Western blot analysis, goat anti-mouse A1 (clone T-18) and donkey anti-goat IgG-horseradish peroxidase (HRP) were Poly(A) ϩ RNA was purified with an oligo-dT column (Invitrogen, Carlsbad, CA), and first-strand cDNA was then from Santa Cruz Biotechnology (Santa Cruz, CA), anti-β-synthesized by a combination of mouse murine leukemia virus Subcloning and in vitro translation (MMLV) (SuperScript II; Gibco/BRL, Grand Island, NY) and The A1 coding region was amplified by RT-PCR with Expand avian aloney virus (Promega, Madison, WI) reverse tranHigh Fidelity enzyme system (Boehringer Mannheim) from scriptases with random hexamers. splenic lymphocyte cDNA. The PCR product was then subcloned by TA cloning into pCR2.1 (Invitrogen) and the PCR primers sequence and orientation verified by sequence analysis with the Sequenase 2.0 kit (USB, Cleveland, OH). The A1 cDNA The primers used in semiquantitative RT-PCR analysis had was then isolated by cleavage with HindIII and EcoRV (Boehrthe following sequences: A1 sense 5Ј-CAAATCTGGCTinger Mannheim) and subcloned into pBluescript II KSϩ GGCTGACTTTTC-3Ј, antisense 5Ј-CAAGTGCTGATAACCA-(Stratagene, San Diego, CA) to create a pBluescript-A1 vector TTCTCGTG-3Ј; β-actin sense 5Ј-GCATTGCTGACAGGATfor in vitro translation studies (Fig. 4) . GCAG-3Ј, antisense 5Ј-CCTGCTTGCTGATCCACATC-3Ј. A1
In vitro translation was accomplished using the TNT Coupled and β-actin primers yielded 123 and 156 bp products respectReticulocyte Lysate System (Promega). Plasmid was linearively. The PCR primers used to amplify the entire coding ized by digestion with EcoRV, purified and added to the rabbit sequence of the A1 cDNA had the following sequence: reticulocyte lysate mixture. Transcription was directed by T3 sense 5Ј-CAACAGCCTCCAGATATGATTAGGG-3Ј, antisense polymerase and translation was carried out in the presence 5Ј-TAACCATTCTCGTGGGAGCCAAGG-3Ј and spanned bp of [ 35 S]methionine. Translation products were then separated 24-694 of the published A1 sequence (36) .
by SDS-PAGE with a 4% stacking gel and a 15% resolving To ensure that amplified sequences corresponded to messgel. The gel was dried and exposed to a phosphorimager and age expression rather than contaminating genomic DNA, PCR newly synthesized protein was detected by [ 35 S]methionine primers for β-actin were designed to span introns. Although incorporation. these A1 primers do not span introns, the A1 product detected is unlikely due to the contamination of genomic DNA because amplification of the same cDNA preparations with intronWestern blot analysis spanning β-actin primers did not yield a genomic fragment.
Cells were washed in protein-free medium, pelleted and Furthermore, amplification of mRNA that had not been reverse lysed on ice for 30 min in a solution of PBS with 1% transcribed did not yield significant β-actin or A1 products.
Triton X-100, 0.1% SDS, 0.5% deoxycholic acids and freshly added proteinase inhibitors, the Complete-Mini cocktail and Semi-quantitative PCR pepstatin A, according to the manufacturer's instructions (Boehringer Mannheim). Cells were then further disrupted by PCR was performed with specific primers to A1 using random several passages through a 21-gauge needle and another primed cDNA. Reactions were carried out with the Expand 30 min incubation on ice. Insoluble material was removed by High Fidelity enzyme system (Boehringer Mannheim, centrifugation. The protein concentration in the lysates was Mannheim, Germany) in the presence of [α- 35 S]dCTP. For measured using the BioRad D c (detergent compatible) Protein each PCR cycle, DNA was denatured at 94°C for 1 min, Assay (BioRad, Hercules, CA) with standards (BSA) of known primers annealed at 57°C for 2 min and new strands elongated protein concentration. at 72°C for 3 min. PCR products were separated on a Lysates were diluted 1:1 in reducing sample buffer denaturing gel (6% acrylamide, 6 M urea, 1ϫTris-borate/ (125 mM Tris-HCl, pH 6.8, 20% glycerol, 4.6% SDS, 10% EDTA), and the presence and quantity of specific amplified 2-mercaptoethanol and 0.05% bromophenol blue) and sequences were detected by incorporation of [α-35 S] dCTP. To denatured for 5 min at 95°C. The proteins were separated ensure that all comparisons were made during the exponential by SDS-PAGE on a 4% stacking gel and a 15% resolving phase of amplification, aliquots were removed at progressive gel. Rainbow colored protein mol. wt markers (Amersham cycles and the amount of product (determined by densitomeLife Science, Arlington Heights, IL) were run alongside. try with a phosphorimager) was plotted against cycle number.
Proteins were transferred onto Hybond-C extra nitrocellulose To control for variations in the rate of amplification, each membrane (Amersham Life Science) in transfer buffer (25 reaction was undertaken in replicate. Relative expression was mM Tris base, 192 mM glycine and 20% methanol) with determined by comparing the amount of product generated 100 mA for 2 h in the cold. The blots were pre-incubated in each population at the same cycle.
for 1 h at room temperature in blocking solution [TBS (10 To ensure that the amount of initial cDNA was equal mM Tris-HCl, pH 8.0, 150 mM NaCl), 5% non-fat milk, for each population, a semi-quantitative PCR using primers 0.05% Tween 20 and either 1 µg/ml donkey (A1) or goat specific to β-actin was performed. A1 expression was then (β-actin) IgG]. The blots were then incubated with primary normalized to the relative β-actin levels. An example of this antibody diluted in blocking solution. To detect A1, blots normalization process is shown in Fig. 2 . When experiments were incubated with 5 µg/ml anti-A1 overnight at 4°C and were separated by time, internal standards were used to then at room temperature for 1 h. To detect β-actin, blots enable comparisons.
were incubated with 0.2 µg/ml anti-β-actin for 1 h at room Our A1 primers regularly amplified two bands~10 bp apart.
temperature. Blots were washed 3 times in TBS with 0.05% Relative expression levels were calculated by comparing the Tween 20 (TBST), incubated with HRP-conjugated secondary intensity of the predicted upper (123 bp) band. Its identity antibody, 1 µg/ml in blocking solution, for 1 h at room with the published A1 cDNA sequence (36) was confirmed temperature, and washed 3 times with TBST. Binding was by TA cloning and sequencing (data not shown). Furthermore, quantification of the lower band yielded the same results.
detected using ECL (Amersham Life Science).
Purification of cell populations by panning associated with recruitment into the long-lived peripheral B cell pool (32) . Because T lymphocytes undergo analogous A suspension of thymocytes from young (4-8 weeks old) mice was prepared by gently teasing dissected thymic lobes in periods of concerted selection and attrition, we wished to determine whether A1 expression varied between immature culture medium with forceps and filtering cells over nylon membrane. Immature, CD4 ϩ CD8 ϩ thymocytes were purified versus mature T lymphocytes. The expression of A1 mRNA in developing DP thymocytes and mature peripheral LN T cells by subjecting the thymic suspension to two rounds of positive panning (30 min at 4°C) on Petri plates which had been was therefore compared. Immature CD4 ϩ CD8 ϩ DP and mature CD4 ϩ CD8 -and CD4 -coated overnight at 37°C with 1 µg/ml anti-CD8 antibody (83-12-5) in PBS containing 100 mM Na 2 CO 3 , pH 8.5. After CD8 ϩ T cells were purified by FACS from thymi and LN of young adult BALB/c mice (Fig. 1) . The mRNA was extracted panning, cells were Ͼ95% CD4 ϩ CD8 ϩ . from these cell preparations and random-primed cDNA synStimulation of T cell populations thesized. Relative amounts of cDNA in different starting Six-well plates were coated with antibody by incubating them preparations were estimated by semi-quantitative PCR for overnight at 4°C in the presence of 1.5 ml of a 10 µg/ml β-actin. The A1 message from these populations was amplified solution of purified anti-TCR antibody (H57-597). After plates and the relative mRNA levels in each T cell population were washed with serum-containing medium, purified immadetermined (Fig. 2 ). ture and mature T cell populations were distributed on six-A1 mRNA was expressed at strikingly high levels among well plates at a density of 10ϫ10 6 cells/well in a total of 2 ml CD4 ϩ CD8 ϩ DP thymocytes. It was also detectable, albeit at culture medium (RPMI, 10% FCS, L-glutamine, NEAA, Na low levels, among both CD4 ϩ CD8 -and CD4 -CD8 ϩ SP LN pyruvate, penicillin/streptomycin and 5ϫ10 -5 M 2-mercapto-T cells. In the representative experiment shown (Fig. 2) , ethanol). Cells were cultured for 8 h at 37°C in a 7.5% CO 2 CD4 ϩ CD8 -and CD4 -CD8 ϩ SP LN T cells expressed 25-and humidified incubator.
75-fold less A1 mRNA than DP thymocytes respectively. Comparisons of numerous preparations indicate that in gen-RT-PCR analyses of panned lymphocyte populations eral, A1 expression is~25-fold higher in DP thymocytes than RNA was isolated from 10 7 fresh and cultured cells with 1 ml among either CD4 ϩ CD8 -or CD4 -CD8 ϩ SP LN T cells (Fig. 3) . RNAzol (Tel-Test, Friendswood, TX) according to the directions of the manufacturer. RNA was ultimately re-dissolved in 20 µl Among thymocyte populations, A1 is expressed at the highest H 2 O. For each cDNA reaction, one-fifth of the RNA preparation levels among DP cells (4 µl) was incubated with 1 µl random hexamer (Boehringer The striking difference in A1 expression between DP thymoMannheim) and 6 µl H 2 O, heated at 95°C for 2 min, then cytes and SP peripheral T cells indicates that substantial placed on ice. cDNA was prepared by adding the following shifts in A1 expression occur during T cell differentiation. To to the RNA/primer mix: 1 µl RNAsin (Promega), 5 µl 5ϫfirst-more precisely define how A1 varies during T cell developstrand buffer (Gibco/BRL), 5 µl 10 mM dNTPs (Amersham), ment, we compared A1 mRNA expression among thymocyte 2 µl 0.1M DTT and 1 µl MMLV reverse transcriptase (Gibco/ subpopulations. Thymocytes were stained with antibodies to BRL), and incubating for 60 s at 37°C. The reaction was CD4 and CD8, and DN, DP and SP cells were fractionated stopped by increasing the temperature to 95°C for 2 min.
by FACS (Fig. 1, upper series) . A1 levels were then examined This cDNA was amplified by adding 4 µl of the cDNA using semi-quantitative RT-PCR. For comparison, the A1 messpreparation to the following mixture: 32.5 µl H 2 O, 5 µl 10ϫTaq age level in the lowest-expressing SP LN preparation was polymerase buffer (Sigma, St Louis, MO), 2.5 µl 5 µM forward arbitrarily assigned unity (Fig. 4) . primer, 2.5 µl 5 µM reverse primer, 1 µl 10 µM dNTPs and A1 mRNA was readily detectable among all thymic subpop-2.5 µl Taq polymerase (Red Taq; Sigma). Forty cycles of ulations (Fig. 4) . DN thymocytes express moderate levels of amplification were performed using an MJ Research PTC-A1, corresponding to~7-fold more than that seen in LN SP 100 thermocycler (with hot bonnet) with 30 s of denaturation populations. A1 is then upregulated a further 3.5-fold upon at 94°C, 30 s of annealing at 55°C for A1 primers and 60°C transit to the DP stage. This is the highest level observed in for β-actin primers, and 45 s of polymerization at 72°C.
any thymic subpopulation and corresponds to~25 times that Aliquots (10 µl) were removed after 30, 35 and 40 cycles, seen among peripheral SP cells. As cells mature and downand separated on a 1.5% agarose gel in 0.5ϫTBE containing regulate either CD4 or CD8, A1 expression decreases. This 0.5 µg/ml ethidium bromide. These reactions employed the decrease appears more pronounced among CD8 SP thymofollowing primers: A1 forward, 5Ј-GCTTTCTCCGTTCAGAAGcytes, but A1 expression is uniformly low in both SP thymocyte GAAGTTG-3Ј; A1 backward, 5Ј-TCAGCCAGCCAGATTTGGsubpopulations. GTTC-3Ј; β-actin forward, 5Ј-GAACATGGCATTGTTACCAAC-TGG-3Ј; β-actin backward, 5Ј-GGATTCCATACCCAAGAAGThe A1 gene encodes a protein of~20 kDa GAAGG-3Ј. These A1 and β-actin primers yielded 346 and
To confirm that alterations in A1 mRNA expression are par-600 bp products respectively.
alleled by changes in protein expression, it was important to examine A1 protein expression among thymic and peripheral Results T cells. While the nucleic acid sequence of A1 predicts a 172 A1 mRNA is expressed at highest levels among DP thymamino acid protein of 20 kDa, with potential N-glycosylation ocytes sites yielding a predicted mol. wt of~21.5 kDa, previous studies had reported detection of a 16 kDa protein (24). Thus, We recently showed that A1 is expressed in B cells and that, unlike Bcl-2, Bax or Bcl-x L , its elevated expression is tightly before proceeding with Western blot analyses of T lymphocyte Aliquots were removed at progressive cycles and run on a denaturing gel, which was then exposed to a phosphorimager. Quantification of these reaction products is detailed in Fig. 3 .
subsets, this anomaly was explored by characterizing the rabbit reticulocyte system, the A1 protein was then synthesized in the presence of [ 35 S]methionine. The products were size of the A1 protein obtained through in vitro translation.
A cDNA containing the complete A1 coding region was separated by SDS-PAGE and autoradiography confirmed the sequence predictions that the A1 protein is indeed~20 kDa amplified by PCR from splenic lymphocyte cDNA. This cDNA was then ligated into pBluescript and its orientation confirmed (Fig. 5 B) . A product of this size was absent from control reactions in which no template was added (data not shown). by sequence analysis (Fig. 5A) . Using in vitro translation in a Fig. 3 . Comparison of expression of A1 mRNA between immature thymocytes and mature LN T cells. Using densitometry with a phosphorimager, the amounts of A1 and β-actin product generated in the RT-PCR reactions pictured in Fig. 2 were calculated. To estimate the relative initial amount of β-actin in each sample, differences in log band intensity during exponential amplification (cycles 26-30) were compared and averaged. To estimate relative A1 mRNA expression, differences in log band intensity during exponential amplification were similarly compared, corrected for differences in initial β-actin expression, then plotted against cycle number. Represented are DP CD4 ϩ CD8 ϩ thymocytes (m), SP CD4 -CD8 ϩ LN T cells (j) and SP CD4 ϩ CD8 -LN T cells (r). actions govern thymocyte development, we were interested to determine whether A1 expression was regulated by T cell receptor engagement. We therefore compared A1 expression in immature CD4 ϩ CD8 ϩ thymocytes from both wild-type and A1 protein is expressed in the thymus but undetectable MHC-deficient mice before and after stimulation with plateamong LN T cells bound anti-TCR antibodies (Fig. 7) . It is apparent from these Levels of A1 protein in developing versus mature T cells were data that (i) freshly isolated ('4°C') CD4 ϩ CD8 ϩ thymocytes compared to establish whether A1 protein expression reflects from wild-type and MHC-deficient mice express similar levels changes in mRNA expression. Accordingly, young adult of A1, and (ii) A1 is unregulated by TCR engagement in both BALB/c thymocytes and MACS-fractionated SP LN T cells cell types. These results indicate that although A1 expression (Fig. 6A) were analyzed for A1 protein by Western blot. The in DP thymocytes is not dependent on TCR-MHC interactions efficiency of available anti-A1 antibodies prevents analyses per se, it is responsive to TCR signaling. These observations of small cell numbers, thus whole thymic lysates, rather than raise the possibility that A1 expression is developmentally thymic subpopulations, were employed. regulated by MHC-independent events that govern the matIn accord with mRNA expression levels, an~20 kDa band uration of DP cells from their DN precursors. They also show was readily detectable in thymic lysates, but in neither of the two SP LN lysates (Fig. 6B) . Thus, A1 mRNA and protein TCR signaling can further regulate A1 expression. suggest that A1 may have a more potent and protracted antiapoptotic activity than either Bcl-x L or Bcl-2. For example, unlike these proteins, the anti-apoptotic activity of A1 cannot Discussion be sequestered by dimerization with the pro-apoptotic protein Bad (28) . In addition, the protease-sensitive (30) loop (29) These studies define the expression of A1, a Bcl-2 family member, among developmental subsets of thymic and perinear the N-terminus of these other Bcl-2 family members is truncated in A1. Deletions in this region appear to confer pheral T cells. The results show that A1 is expressed at moderate levels among DN thymocytes, then up-regulated to greater anti-apoptotic ability (31), alter susceptibility to phosphorylation (31) and may lengthen protein half-life (30) . high levels among CD4 ϩ CD8 ϩ DP thymocytes. A1 mRNA is expressed at only moderate levels among SP thymocytes Despite its anti-apoptotic abilities, A1 is expressed at the highest levels among DP thymocytes, whose turnover time is and is found at low levels in SP peripheral T cell populations. A1 expression in DP thymocytes is comparable in MHC only~4 days (1,2,37,38), whereas the lowest A1 expression levels are among SP peripheral T cells, whose average knockout and wild-type mice, indicating that A1 up-regulation within this subset is independent of TCR-MHC engagement.
lifespan ranges from months to 1 year (39, 40) . Thus, among T lineage cells, a high level of A1 per se is neither necessary However, TCR signaling can drive A1 expression, since all TCR ϩ T cell populations examined markedly up-regulate A1 nor sufficient to confer long lifespan. Further, since it is thought that most DP thymocyte death reflects neglect (4,41), upon anti-TCR stimulation in vitro. Finally, we show that A1 encodes a~20 kDa protein and that like its mRNA, this protein heightened levels of A1 do not overcome the need for positive selection. This is consistent with previous observations in is expressed at higher levels among developing thymocytes than mature peripheral T cells. These findings, in conjunction transgenic systems, which showed that elevated levels of other anti-apoptotic Bcl-2 family members neither bypass with our previous studies of A1 expression during B cell development, suggest A1 plays a role during T cell developpositive selection (42) nor over-ride negative selection (17,18,20,21,42). ment and selection.
A1 is an anti-apoptotic member of the Bcl-2 family (24-26). Interestingly, A1 is up-regulated in both DP thymocytes and 
